Abattis Bioceuticals Corp. (ATTBF)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Apr 24, 2025, 4:00 PM EDT
Abattis Bioceuticals Cash Flow Statement
Financials in millions CAD. Fiscal year is October - September.
Millions CAD. Fiscal year is Oct - Sep.
Fiscal Year | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | 2010 - 2014 |
|---|---|---|---|---|---|---|
Period Ending | Sep '19 Sep 30, 2019 | Sep '18 Sep 30, 2018 | Sep '17 Sep 30, 2017 | Sep '16 Sep 30, 2016 | Sep '15 Sep 30, 2015 | 2010 - 2014 |
| Net Income | -3.04 | -78.01 | -7.63 | -2.34 | -4.47 | Upgrade
|
| Depreciation & Amortization | 0.11 | 0.04 | 0.09 | 0.13 | 0.18 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | -0.01 | - | - | 0.39 | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.05 | 10.47 | 0.95 | - | 2.34 | Upgrade
|
| Loss (Gain) From Sale of Investments | -0.76 | 5.85 | - | 0.01 | 0.3 | Upgrade
|
| Loss (Gain) on Equity Investments | - | 0.87 | - | - | - | Upgrade
|
| Stock-Based Compensation | 0.22 | 7.88 | 4.7 | 1.48 | 0.55 | Upgrade
|
| Provision & Write-off of Bad Debts | - | 0.01 | - | - | 0.16 | Upgrade
|
| Other Operating Activities | 4.39 | 45.33 | 0.48 | -0.32 | -1.81 | Upgrade
|
| Change in Accounts Receivable | 0.39 | -0.46 | -0.09 | 0 | 0.07 | Upgrade
|
| Change in Inventory | -0.24 | -0.03 | 0.29 | - | - | Upgrade
|
| Change in Accounts Payable | 1.37 | -0.14 | - | - | 0.45 | Upgrade
|
| Change in Other Net Operating Assets | 6.92 | -0.09 | -0.01 | 0.31 | 0.01 | Upgrade
|
| Operating Cash Flow | 9.41 | -8.28 | -1.22 | -0.73 | -1.82 | Upgrade
|
| Capital Expenditures | -0.06 | -0.23 | -0.43 | -0.05 | -0.04 | Upgrade
|
| Cash Acquisitions | - | -6 | - | - | - | Upgrade
|
| Divestitures | - | 2 | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | -5 | - | -0 | -0 | -0 | Upgrade
|
| Investment in Securities | -6.46 | -12 | - | 0.08 | 1.05 | Upgrade
|
| Other Investing Activities | - | - | - | 0.01 | 0.24 | Upgrade
|
| Investing Cash Flow | -11.52 | -16.23 | -0.43 | 0.04 | 1.12 | Upgrade
|
| Long-Term Debt Issued | - | - | - | 0.03 | - | Upgrade
|
| Total Debt Issued | - | - | - | 0.03 | - | Upgrade
|
| Net Debt Issued (Repaid) | - | - | - | 0.03 | - | Upgrade
|
| Issuance of Common Stock | 0.06 | 28.05 | 2.14 | 0.57 | 0.72 | Upgrade
|
| Other Financing Activities | - | - | - | -0.03 | - | Upgrade
|
| Financing Cash Flow | 0.06 | 28.05 | 2.14 | 0.57 | 0.72 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | - | - | 0 | 0 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | 0 | -0 | - | - | - | Upgrade
|
| Net Cash Flow | -2.04 | 3.54 | 0.49 | -0.12 | 0.02 | Upgrade
|
| Free Cash Flow | 9.35 | -8.51 | -1.65 | -0.78 | -1.86 | Upgrade
|
| Free Cash Flow Margin | 2620.32% | -101698.69% | - | - | -2021.59% | Upgrade
|
| Free Cash Flow Per Share | 0.02 | -0.03 | -0.01 | -0.01 | -0.03 | Upgrade
|
| Levered Free Cash Flow | -2.46 | -7.2 | -3.7 | -1.3 | -0.57 | Upgrade
|
| Unlevered Free Cash Flow | -2.43 | -4.49 | -3.7 | -1.3 | -0.56 | Upgrade
|
| Change in Net Working Capital | -4.75 | 1.35 | 0.69 | 0.06 | -0.62 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.